Answers are grounded in this paper and cite their sources.
Hedgehog interacting protein (Hhip) promotes tubular senescence and tubulopathy in diabetic kidney disease (DKD), but the underlying mechanisms remain incompletely understood. We investigated whether the senolytics (Dasatinib, D/Quercetin, Q) attenuate Hhip-associated renal proximal tubular cell (RPTC) senescence and tubulopathy. Murine diabetes was induced by low-dose streptozotocin in male RPTC-specific Hhip transgenic (HhipRPTC-Tg) and non-Tg mice, with or without D/Q treatment (D, 5 mg/kg, and Q, 50 mg/kg, by oral gavage for 3 consecutive days every 2 weeks). Primary RPTCs and immortalized rat RPTCs (IRPTCs) were used for in vitro studies. Diabetic mice developed RPTC tubulopathy, manifested by increased tubular senescence and oxidative stress, which was further exacerbated in diabetic HhipRPTC-Tg mice but significantly attenuated by D/Q treatment. D/Q improved mitochondrial network morphologic integrity in IRPTCs. Mechanistically, PTEN-induced kinase 1 (Pink1) expression increased in diabetes, whereas optineurin (Optn) expression, although increased relative to non-diabetic controls, was lower in diabetic HhipRPTC-Tg than diabetic non-Tg mice. Senolytics (D/Q) restored both Pink1 and Optn expression levels in RPTCs in vivo and in vitro, while also improving mitochondrial morphology in vitro. These findings suggest that senolytics (D/Q) attenuate Hhip-mediated RPTC senescence and tubulopathy in DKD, potentially involving altered Pink1–Optn-mediated mitophagy, which warrants further validation.
No takes yet. Share an insight, caveat, or question.
Chang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: